White label ELPA - ClinicalTrials.eu

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Not recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
+5
Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Not recruiting

3 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
+2
Study on the Effectiveness and Safety of Deucravacitinib for Adults with Chronic Hand Eczema

Not recruiting

2 1 1
Investigated diseases:
- Hand dermatitis
Investigated drugs:
- Deucravacitinib
Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Not recruiting

3 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
+2
Study of Risdiplam for Infants with Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Not recruiting

2 1 1 1
Investigated diseases:
- Spinal muscular atrophy
Investigated drugs:
- Risdiplam
Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+4
Gene Therapy Study for Patients with Limb-Girdle Muscular Dystrophy Using GNT0006

Not recruiting

2 1 1 1
Investigated diseases:
- Muscular dystrophy
Investigated drugs:
Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer stage III
Investigated drugs:
- Brigatinib
- Durvalumab
Study on the Safety and Effects of Setanaxib for Patients with Alport Syndrome

Not recruiting

2 1
Investigated diseases:
- Alport’s syndrome
Investigated drugs:
- Setanaxib
Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated diseases:
- Hidradenitis
Investigated drugs:
- Izokibep

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies